Metropolitan Hospital, Athens, Greece
Wed 04 12:00
Publishing case reports in EDMCR
Metropolitan Hospital, Athens, Greece
Imperial College, London, United Kingdom
Mon 02 13:55
PL2
Using kisspeptin to interrogate hypothalamic dysfunction in reproductive disorders
Imperial College, London, United Kingdom
Nottingham Trent University, Nottingham, UK
Tue 03 15:15
OC6.1
Integrative Multi-Omics Analysis Reveals Epigenetic Regulation of Placental Genes Associated with Maternal B12 Deficiency
Nottingham Trent University, Nottingham, UK
The Christie NHS Foundation Trust, Manchester, UK
Tue 03 12:10
S1.3
Paraneoplastic Cushing’s
The Christie NHS Foundation Trust, Manchester, UK
Royal College of Surgeons in Ireland (RCSI), Dublin, UK
Tue 03 14:03
OP4.2
SGK3 and Lipid Remodelling: A Key Player in Androgen-Mediated Metabolic Dysregulation in Endocrine-Resistant Breast Cancer
Royal College of Surgeons in Ireland (RCSI), Dublin, UK
University of Leicester, Leicester, UK
Tue 03 13:28
OP3.2
Redox Modulation Enhances the Metabolic Efficacy of SGLT2 Inhibition
University of Leicester, Leicester, UK
County Hospital, Stafford, UK
Mon 02 15:45
OC3.6
Comparative Effectiveness of Bariatric Surgery vs. Pharmacologic Weight Loss on Bone Health and Fracture Risk in Asian Population
County Hospital, Stafford, UK
University of Leicester, Leicester, UK
Mon 02 15:45
OC4.6
Mapping the Mutational Landscape of Thyroid Carcinoma Using Whole-Exome Sequencing
University of Leicester, Leicester, UK
University of Birmingham, Birmingham, UK
Mon 02 12:53
OP2.2
Loss of 11β-HSD1 Attenuates Skeletal Muscle Atrophy During Glucocorticoid Therapy in Experimental Kidney Injury
University of Birmingham, Birmingham, UK
University of Edinburgh, Edinburgh, UK
Wed 04 11:40
Tips for publishing impactful research
University of Edinburgh, Edinburgh, UK
University College London, London, UK
Mon 02 14:45
OC2.2
Imaging Adrenal Aldosterone Synthase Expression with [18F]AldoView PET-CT in Primary Aldosteronism
University College London, London, UK
Queen Mary University of London, London, UK
Mon 02 15:15
OC2.4
Sphingosine Kinase 2 (SPHK2) inhibition as a therapeutic strategy for Adrenocortical Carcinoma (ACC)
Queen Mary University of London, London, UK
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Mon 02 15:30
OC2.5
Rationalising the use of hypertonic saline-stimulated copeptin measurements in differentiating between AVP deficiency and primary polydipsia
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Kings College London, London, UK
Wed 04 10:05
S6.3
Egg freezing- meeting social and clinical needs
Kings College London, London, UK
University of Birmingham, Birmingham, UK
Wed 04 10:50
Guy's and St Thomas' NHS Foundation Trust, London, UK
Tue 03 11:05
NKM1
Endocrine Nursing across the years - from acorns to great oaks
Guy's and St Thomas' NHS Foundation Trust, London, UK
University of Exeter, Exeter, UK
Tue 03 10:55
OCP1
Pituitary Ambassador for the Pituitary Foundation
Tue 03 16:15
NS2.3
The patient journey and the role of patient support groups
Pituitary Ambassador for the Pituitary Foundation
York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK
Tue 03 18:05
NS3.2
New Guidance: Hypoparathyroidism – what’s new, NICE and how nurses are integral to this
York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK
NYU Neuroscience Institute, New York, USA
Mon 02 16:25
PL3
Brain-body control by the hippocampus
NYU Neuroscience Institute, New York, USA
Imperial College London, London, UK
Mon 02 13:09
OP2.4
Biased Agonism Can Modulate Response to GLP-1R Therapy Through Altered Surface Availability in the CNS.
Imperial College London, London, UK
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 03 11:55
S1.2
Insulinoma
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
University of Edinburgh, Edinburgh, United Kingdom
Tue 03 17:15
PL6
Stress, steroids and serendipity
University of Edinburgh, Edinburgh, United Kingdom
Bad Nauheim, Germany
Tue 03 12:10
S2.2
The Role of Insulin Resistance and Adrenomedullin in Endothelial Cells
Bad Nauheim, Germany
St Bartholomew’s Hospital, London , UK
Tue 03 15:45
NS2.2
The role of the endocrine nurse in managing complex Cushing’s disease
St Bartholomew’s Hospital, London , UK
Imperial College London, London, UK
Tue 03 15:45
OC6.3
Beneficial Effect of Protein-Induced Glucose Tolerance is Independent of Protein-Induced Insulin Release
Imperial College London, London, UK
Guy's & St Thomas' NHS Foundation Trust, London, UK
Tue 03 12:10
NS1.2
Presentation 2
Guy's & St Thomas' NHS Foundation Trust, London, UK
Queen Elizabeth University Hospital, Glasgow, UK
Wed 04
Hormone and risk management across the lifespan in transgender patients
Queen Elizabeth University Hospital, Glasgow, UK
University of Edinburgh, Edinburgh, UK
Tue 03 08:35
ER1.1
Emerging Researcher Lecture (Science): Role of Obesity Gene PLXNA4 in Neurodevelopment and Anxiety
University of Edinburgh, Edinburgh, UK
Queen Mary University of London, London, UK
Mon 02 14:30
OC3.1
Investigating fertility and reproductive ageing in a Down syndrome mouse model
Queen Mary University of London, London, UK
University of Birmingham, Birmingham, UK
Mon 02 09:25
WIN2
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, Coventry, UK
Tue 03 12:40
NS1.3
Supporting patients with Obesity
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, Coventry, UK
University of Oxford, Oxford, UK
Tue 03 16:00
OC7.4
Peripartum increases in serum prolactin and differential mammary prolactin receptor isoform expression are associated with human secretory activation
University of Oxford, Oxford, UK
University College London, London, UK
Wed 04 11:40
Updates in diagnosis and management of POI
University College London, London, UK
University of Nebraska Medical Center, Nebraska, USA
Wed 04 09:35
S6.2
The corpus luteum
University of Nebraska Medical Center, Nebraska, USA
Sheffield Teaching Hospital , Sheffield, UK
Tue 03 14:35
MTE1
Managing Congenital Adrenal Hyperplasia - Optimising Treatment Strategies
Sheffield Teaching Hospital , Sheffield, UK
Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United States
Tue 03 11:05
TAA1
My journey in medicine and endocrinology
Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United States
Imperial College London, London, UK
Tue 03 14:11
OP4.3
Optimising Glucocorticoid Replacement in Adrenocortical Cancer: The Role of ACTH Monitoring
Imperial College London, London, UK
University of Edinburgh, Edinburgh, UK
Mon 02 11:25
Developing a strategy to improve energy expenditure in PCOS
King's College London, London, UK
University of Edinburgh, Edinburgh, UK
King’s College London, London, UK
Wed 04 16:02
HDI2.5
Building back bone and improving fracture risk – what you can do for your patients, right now
King’s College London, London, UK
Imperial College London, London, UK
Tue 03 09:25
ER1.4
Best Basic Abstract: Visualising microvascular changes in digestive organs during the onset of type 2 diabetes with super-resolution ultrasound
Imperial College London, London, UK
The University of Edinburgh, Edinburgh, UK
Wed 04 09:05
S6.1
Ovarian follicle activation and exposures affecting ovarian reserve
The University of Edinburgh, Edinburgh, UK
Imperial College London, London, UK
Mon 02 15:00
OC3.3
Short-Term Oestradiol Variability Across HRT Preparations in Postmenopausal Women
Imperial College London, London, UK
Royal Surrey Hospital, Surrey, UK
Tue 03 12:55
S1.6
Adrenal mass in pregnancy
Royal Surrey Hospital, Surrey, UK
Glan Clwyd Hospital, Rhyl, UK
Tue 03 15:45
OC7.3
Charting the clinical course of immune checkpoint inhibitor-related endocrinopathies amongst 833 ICI-treated patients in North Wales
Glan Clwyd Hospital, Rhyl, UK
Queen Elizabeth Hospital Birmingham and Aston University, Birmingham, UK
Centre for Health and Life Sciences, Coventry, UK
Tue 03 16:15
OC7.5
Insights into Somatostatin Analogue Response: Alterations in SSTR and Ki-67 Expression in LCC-18 Neuroendocrine Tumour Cells
Centre for Health and Life Sciences, Coventry, UK
Imperial College London, London, UK
Mon 02 14:30
OC2.1
Peri-Prostatic Adipose Tissue Drives Obesity-Associated Prostate Cancer Aggressivity via Extracellular Vesicles and Rho GTPase Signalling
Imperial College London, London, UK
Wed 04 10:50
Wed 04 10:55
Identification of a non-invasive microRNA-based diagnostic biomarker panel for prostate cancer
Imperial College London, London, UK
Wed 04 11:25
QMUL, London, UK
Tue 03 13:20
OP3.1
A Role for Non-Muscle Myosin IIA in Adrenocortical Carcinoma
QMUL, London, UK
University of Southern Denmark , Denmark
Mon 02 11:20
Skeletal consequences of GLP-1 based therapies
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
University of Southern Denmark , Denmark
London, United Kingdom
Wed 04 09:35
S4.2
Borderline thyroid dysfunction in fertility clinics
London, United Kingdom
University Hospitals Birmingham, Birmingham, UK
Tue 03 08:15
The Latest ESE guidance on Hypoparathyroidism
University Hospitals Birmingham, Birmingham, UK
University of Birmingham and Queen Elizabeth Hospital, Birmingham, UK
Wed 04 12:44
OP6.4
Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From the Phase 3 PaTHway Trial
University of Birmingham and Queen Elizabeth Hospital, Birmingham, UK
Mon 02 11:50
Introduction to HISTAR score, a tool to predict cure in primary aldosteronism
University of Cambridge, Cambridge, UK
Wed 04 08:30
Functional imaging in tricky pituitary cases
University of Cambridge, Cambridge, UK
Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mon 02 15:15
OC3.4
DNA methylation of Gonadotropin-Releasing Hormone Regulatory Genes is altered in Human Delayed Puberty
Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Imperial College Healthcare NHS Trust, London, UK
Wed 04 11:50
Metabolic Surgery and Beyond
Imperial College Healthcare NHS Trust, London, UK
University of Birmingham, Birmingham, UK
Mon 02 11:20
Skeletal consequences of GLP-1 based therapies
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
University of Southern Denmark , Denmark
MRC Laboratory of Medical Sciences, London, UK
Mon 02 15:00
OC1.3
Serum steroid metabolomics is inferior to urine steroid metabolomics in the detection of adrenocortical carcinoma
MRC Laboratory of Medical Sciences, London, UK
Salford Royal Hospital, Salford, UK
Wed 04 13:11
OP7.3
A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women with Hypoactive Sexual Desire Disorder (HSSD) Already Receiving this as Part of Usual Care in Conjunction with Oestrogen Containing Hormone Replacement Treatment (HRT)
Salford Royal Hospital, Salford, UK
Guy's & St Thomas' NHS Foundation Trust, London, UK
Tue 03 11:40
NS1.1
Presentation 1
Guy's & St Thomas' NHS Foundation Trust, London, UK
London, UK
Imperial College London, London, UK
Mon 02 15:15
OC1.4
Improved Wellbeing and Reduced Cardiometabolic Risks with Once-daily Low-dose Prednisolone in Adrenal Insufficiency: Interim Results from the Hyper-Aid Study
Imperial College London, London, UK
University of Bergen, Bergen, Norway
Mon 02 13:25
PL1
Autoimmune regulator and polyendocrine syndromes
University of Bergen, Bergen, Norway
University of Cambridge, Cambridge, UK
Mon 02 15:00
OC2.3
Retrospective Review of the Management of Head and Neck Paragangliomas in a UK PPGL Centre of Excellence
University of Cambridge, Cambridge, UK
Imperial College London, London, UK
Wed 04 08:30
Improving the treatment of patients with reproductive hormonal disorders
Imperial College London, London, UK
University of Gothenburg, Gothenburg, Sweden
Mon 02 10:15
WS1.2
GLP-1 receptor agonists to combat addiction
University of Gothenburg, Gothenburg, Sweden
King's College London, London, UK
Mon 02 11:25
Developing a strategy to improve energy expenditure in PCOS
King's College London, London, UK
University of Edinburgh, Edinburgh, UK
Imperial College London, London, UK
Wed 04 12:55
OP7.1
Adaptive Metabolic Plasticity Defends Body Reserves During Reproduction
Imperial College London, London, UK
Imperial College London, London, UK
Johannes Gutenberg University Medical Center, Mainz, Germany
Mon 02 15:30
OC4.5
Batoclimab Induces Very Rapid and Sustained Post-treatment Euthyroidism in Graves’ Disease
Johannes Gutenberg University Medical Center, Mainz, Germany
Nottingham Trent University, Nottingham, UK
Mon 02 12:45
OP2.1
miR-10b-5p promotes brown adipocyte differentiation and the thermogenic program in white adipose tissue.
Nottingham Trent University, Nottingham, UK
Birmingham, UK
Tue 03 17:45
PL7
Pituitary Troubles and the Mitos for the Labyrinth
Birmingham, UK
The Royal Wolverhampton Trust, Wolverhampton, UK
Mon 02 14:45
OC4.2
Neutrophil count and neutropenia in newly diagnosed hyperthyroidism: Ethnic variation and TRAb–Free-T4 interaction
The Royal Wolverhampton Trust, Wolverhampton, UK
University of Birmingham, Birmingham, UK
Wed 04
OP5.4
Enhancing Endocrine Training Through Virtual Simulation: Addressing Social Determinants of Health, Health Inequities and Multiple Long-Term Conditions
University of Birmingham, Birmingham, UK
University of Birmingham, Birmingham, UK
Wed 04
OP5.1
Postgraduate Educational Methods in Diabetes, Endocrinology and Metabolism (PEMDEM): A Systematic Review of Training Approaches and Their Impact on Clinical Competence and Patient Care
University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Mon 02 14:45
OC3.2
Kisspeptin challenge test reveals hypothalamic dysfunction in obesity-related hypogonadism
Imperial College London, London, UK
University of Cambridge, Cambridge, UK
Mon 02 12:26
OP1.3
HypoMap3D: A reference spatio-cellular atlas of the mouse hypothalamus for studying neuroendocrine biology and disorders
University of Cambridge, Cambridge, UK
St Bartholomhew's Hospital, London, UK
Wed 04
OP5.2
EndocrineDigiSim: A Pilot Study of Digital Endocrine Consultation Simulation for Postgraduate Medical Training
St Bartholomhew's Hospital, London, UK
King's College London, London, UK
Tue 03 16:30
OC6.6
Decoding the obese duodenal cell atlas
King's College London, London, UK
University of Oxford Hospitals, Oxford, UK
Tue 03 17:45
NS3.1
Intro/ Overview
University of Oxford Hospitals, Oxford, UK
Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mon 02 12:34
OP1.4
Autistic spectrum disorders and heterogenous pituitary phenotype in patients with AIP variants
Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Beaumont Hospital, Dublin, Ireland
Tue 03 12:10
S3.2
Transcription factor analysis of null cell adenomas
Beaumont Hospital, Dublin, Ireland
Queen Elizabeth University Hospital, Glasgow, UK
Tue 03 15:15
OC7.1
Predictive value of day-7 serum cortisol for hypothalamic–pituitary–adrenal axis recovery following transsphenoidal surgery
Queen Elizabeth University Hospital, Glasgow, UK
University of Oxford, Oxford, UK
Wed 04 12:20
OP6.1
CCN family member 3 (CCN3) is a potential human osteoanabolic lactation hormone
University of Oxford, Oxford, UK
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Tue 03 14:35
MTE4
Navigating the complexities of GHD: Transition to Adulthood
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Manchester University NHS Foundation Trust, Manchester, UK
Tue 03 13:36
OP3.3
Salivary hybrid steroids and the sub-classification of primary aldosteronism: a pilot study
Manchester University NHS Foundation Trust, Manchester, UK
Imperial College London, London, UK
Mon 02 09:10
WIN1
Children’s Health Ireland at Temple Street, Dublin, Ireland
Mon 02 15:30
OC3.5
Improvements in Lower Extremity Alignment are Associated with Physical Functioning in Children with Achondroplasia Treated with Navepegritide: 52-Week Results from the ApproaCH Trial
Children’s Health Ireland at Temple Street, Dublin, Ireland
University of Glasgow, Glasgow, UK
Tue 03 14:19
OP4.4
GloBE-Reg: A Global Registry for Evaluating the Safety and Effectiveness of Growth Hormone Therapy Across The Age Span
University of Glasgow, Glasgow, UK
Royal College of Surgeons in Ireland, Dublin, Ireland
Tue 03 13:44
OP3.4
Weight loss induced by bariatric surgery impacts significantly on serum and urinary mineralocorticoid metabolism in men and women
Royal College of Surgeons in Ireland, Dublin, Ireland
Imperial College London, London, UK
Tue 03 16:15
OC6.5
A targeted epi-drug screen identifies HDAC6 inhibition as an enhancer of beta cell function and immune evasion
Imperial College London, London, UK
Imperial College London, London, UK
Tue 03 13:55
OP4.1
Computer-Assisted Cytopathological Diagnosis in Pancreatic Tumours: A Systematic Review and Meta-Analysis
Imperial College London, London, UK
Newcastle University, Newcastle, UK
Mon 02 10:57
HDI1.5
The University of Edinburgh , Edinburgh, UK
Tue 03 14:35
MTE3
Fertility preservation in male childhood cancer
The University of Edinburgh , Edinburgh, UK
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 02 10:39
HDI1.4
Follow up patients with acromegaly
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 03 11:40
S3.1
Oral somatostatin analogue therapy for pituitary disease
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
James Cook University Hospital, Middlesbrough, UK
Mon 02 10:03
HDI1.2
Imperial College London, London, UK
Wed 04 13:19
OP7.4
Disentangling the impact of Obesity on Reproductive, Metabolic and Adipokine Profiles in Women with or without PCOS
Imperial College London, London, UK
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Tue 03 11:40
S1.1
Secretory PPGL
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Imperial College London, London, UK
Tue 03 16:00
OC6.4
High Fracture Rates in Obesity Despite Normal Bone Mineral Density
Imperial College London, London, UK
St James Hospital, Dublin, Ireland
Mon 02 09:45
HDI1.1
St James Hospital, Dublin, Ireland
Wed 04 09:05
Conn-undrums - a deep dive into diagnostic pitfalls
St James Hospital, Dublin, Ireland
Newcastle University, Newcastle upon Tyne, UK
Wed 04 09:05
S4.1
Novel treatments for managing autoimmunity in Graves' disease
Newcastle University, Newcastle upon Tyne, UK
Wed 04 11:22
UK clinical trials for Grave’s disease
Newcastle University, Newcastle upon Tyne, UK
Camurus AB, Lund, Sweden
Tue 03 16:30
OC7.6
Long-term and sustained biochemical control of acromegaly and improved quality of life with CAM2029 octreotide subcutaneous depot: final analysis of the core phase of ACROINNOVA 2
Camurus AB, Lund, Sweden
Queen Elizabeth University Hospital, Birmingham, UK
Mon 02 11:20
Skeletal consequences of GLP-1 based therapies
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
University of Southern Denmark , Denmark
Imperial College London, London, UK
Tue 03 08:55
ER1.2
Emerging Researcher Lecture (Clinical): Kisspeptin-54 accurately identifies the cause of delayed puberty
Imperial College London, London, UK
Barts NHS Trust Cambridge University Hospital NHS Trust , Cambridge , UK
Tue 03 12:25
S1.4
Secretory ACC
Barts NHS Trust Cambridge University Hospital NHS Trust , Cambridge , UK
Tue 03 15:15
NS2.1
TITLE TBC
Barts NHS Trust Cambridge University Hospital NHS Trust , Cambridge , UK
Queen Elizabeth Hospital, Birmingham, UK
Mon 02 11:20
Consensus statement about Mild Autonomous Cortisol Secretion
Queen Elizabeth Hospital, Birmingham, UK
British Thyroid Foundation, Harrogate , UK
Wed 04 11:14
Information for patients with TED
British Thyroid Foundation, Harrogate , UK
Imperial College London, London, UK
Mon 02 11:20
Introduction to Reproductive Endocrinology Endocrine Network
Imperial College London, London, UK
Queen Elizabeth Hospital Birmingham and Aston University, Birmingham, UK
Tue 03 15:45
OC7.3
Charting the clinical course of immune checkpoint inhibitor-related endocrinopathies amongst 833 ICI-treated patients in North Wales
Glan Clwyd Hospital, Rhyl, UK
Queen Elizabeth Hospital Birmingham and Aston University, Birmingham, UK
Queen Mary University of London, London, UK
Mon 02 12:18
OP1.2
MECP2 as a regulator of transcription and chromatin conformation in GnRH neurons: implications for puberty.
Queen Mary University of London, London, UK
Tue 03 15:30
OC7.2
Defective Nitric Oxide Pathway Signalling - a Link Between Premature Birth and Altered Mini-Puberty?
Queen Mary University of London, London, UK
University of Birmingham, Birmingham, UK
Wed 04 11:29
Update on translational studies to enhance NIS function
University of Birmingham, Birmingham, UK
Cardiff University, Cardiff, UK
Mon 02 14:30
OC1.1
Replacing the early morning cortisol rise reduces fatigue and improves QoL in adrenal insufficiency: a double-blind study
Cardiff University, Cardiff, UK
Bournemouth
Wed 04 11:06
Using artificial intelligence to predict antithyroid drug dosage
Bournemouth
University of Birmingham, Birmingham, UK
Mon 02 14:45
OC1.2
Validation of prognostic biomarkers in adrenocortical carcinoma through Next-Generation Sequencing and pyrosequencing in a real-life setting.
University of Birmingham, Birmingham, UK
University of Birmingham, Birmingham, United Kingdom
Wed 04 11:50
The peer-review process
University of Birmingham, Birmingham, United Kingdom
University of Sheffield , Sheffield , UK
Tue 03 09:40
PL4
A 60-year odyssey with bisphosphonates, bone biology and beyond
University of Sheffield , Sheffield , UK
Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK
Mon 02 15:45
OC1.6
Childhood Androgen Excess and Metabolic Risk: A Case-Control Study in Premature Adrenarche and Adolescent Polycystic Ovary Syndrome
Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK
Heartlands Hospital, Birmingham, UK
Mon 02 13:01
OP2.3
Efficacy of GLP-1 Receptor Agonists in Patients with Prader–Willi Syndrome: A Retrospective Cohort Study
Heartlands Hospital, Birmingham, UK
University of Cambridge, Cambridge , UK
Mon 02 10:21
HDI1.3
Wed 04 08:30
Massachusetts General Hospital, Boston, Massachusetts
Wed 04 14:05
PL9
Title TBC
Massachusetts General Hospital, Boston, Massachusetts
University of Edinburgh, Edinburgh, UK
Wed 04 10:05
Low glucose, high stakes - investigation of spontaneous hypoglycaemia
University of Edinburgh, Edinburgh, UK
The Francis Crick insitute , London , UK
Tue 03 14:20
MTE2
Belzutifan - VHL and beyond
The Francis Crick insitute , London , UK
University of Nottingham, Nottingham, UK
Wed 04 13:03
OP7.2
Low Protein Diet Alters Embryo Morphology and 1-Carbon Metabolism in Mice
University of Nottingham, Nottingham, UK
London Northwest University Hospital NHS Trust, London, UK
Mon 02 12:10
OP1.1
Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Clinical Presentation, Diagnosis, and Management
London Northwest University Hospital NHS Trust, London, UK
Wed 04
OP5.5
Inpatient Hyponatraemia diagnosis and management
London Northwest University Hospital NHS Trust, London, UK
Res Consortium, Andover, UK
Mon 02 15:15
OC4.4
Evaluating Levothyroxine Cessation and Thyroid Status: A City-Wide Population Record Analysis
Res Consortium, Andover, UK
Mersey and West Lancashire Teaching Hospitals NHS Trust, St Helens, UK
Wed 04 12:36
OP6.3
An Endocrine Nurse led Cinacalcet Clinic? Saving money, avoiding admissions and keeping patient safe!
Mersey and West Lancashire Teaching Hospitals NHS Trust, St Helens, UK
University of Birmingham, Birmingham, UK
Mon 02 14:30
OC4.1
Functional Characterization of Two Different NAH-Associated Activating TSHR Mutations
University of Birmingham, Birmingham, UK
Wed 04 10:50
Wed 04 11:10
Immune Check point inhibitor induced Endocrinopathy Registry
Wed 04 11:25
University of Cambridge, Cambridge, UK
Wed 04 14:50
CET1.1
What has single cell sequencing told us about the hypothalamus?
University of Cambridge, Cambridge, UK
Imperial College London, London, United Kingdom
Mon 02 09:45
WS1.1
GLP-1 receptor agonists and metabolic improvement in PCOS
Imperial College London, London, United Kingdom
Imperial College London, London, UK
Tue 03 15:30
OC6.2
Identifying High-Risk Women After GDM: Multivariate Analysis of Routine Clinical Metrics for Postpartum Dysglycaemia
Imperial College London, London, UK
University of Birmingham, Birmingham, UK
Wed 04
OP5.3
Hormone Hype and Health Misinformation: Social Media Marketing of Cortisol and Testosterone.
University of Birmingham, Birmingham, UK
Wed 04 15:20
CET1.2
What can mass spectrometry do for Endocrinologists?
University of Birmingham, Birmingham, UK
Cardiff University, Cardiff, UK
Wed 04 10:58
Iodine Status in the United Kingdom
Cardiff University, Cardiff, UK
University of Birmingham, Birmingham, UK
Wed 04
OP5.3
Hormone Hype and Health Misinformation: Social Media Marketing of Cortisol and Testosterone.
University of Birmingham, Birmingham, UK
Wed 04 15:20
CET1.2
What can mass spectrometry do for Endocrinologists?
University of Birmingham, Birmingham, UK
Mon 02 10:45
WS1.3
GLP-1 receptor agonists to treat liver disease
Tue 03 12:40
S2.3
Causes and consequences of diabetes kidney disease
Wed 04 10:05
S4.3
Radiofrequency ablation of benign thyroid nodules
Wed 04 15:50
CET1.3
How can AI advance our understanding of endocrine systems
The Christie NHS Foundation Trust, Manchester, UK
Mon 02 15:30
OC1.5
Validating the Utility of Morning Salivary Cortisone in the Assessment for Adrenal Insufficiency
The Christie NHS Foundation Trust, Manchester, UK
MRC LMS, London, UK
Wed 04 12:28
OP6.2
Characterisation of human sulfotransferases involved in vitamin D metabolite sulfation and population-level variation in sulfation
MRC LMS, London, UK
Newcastle Hospital NHS Foundation Trust, Newcastle , UK
Tue 03 12:40
S1.5
Tricky growing indeterminate lesions (eg myelolipoma)
Newcastle Hospital NHS Foundation Trust, Newcastle , UK
Norfolk and Norwich University Hospital, Norwich, UK
Tue 03 09:15
ER1.3
Best Clinical Abstract: Improved Skeletal Dynamics in Adults Treated with Palopegteriparatide for Chronic Hypoparathyroidism: 214-Week Results from the Phase 2 PaTH Forward Trial
Norfolk and Norwich University Hospital, Norwich, UK
Erasmus Medical Center, Rotterdam, The Netherlands
Tue 03 10:10
PL5
From mutation to medicine: a story of MCT8 deficiency
Erasmus Medical Center, Rotterdam, The Netherlands
Departement Gesundheitswissenschaften und Technologie, ETH Zurich
Tue 03 11:40
S2.1
The fat remembers: epigenetic changes in adipose tissue in obesity
Departement Gesundheitswissenschaften und Technologie, ETH Zurich
Imperial College London, London, UK
Wed 04 12:55
OP7.1
Adaptive Metabolic Plasticity Defends Body Reserves During Reproduction
Imperial College London, London, UK
Imperial College London, London, UK
London
Tue 03 12:40
S3.3
Recognition and management of aggressive pituitary tumours
London
University of Liverpool, Liverpool, UK
Wed 04 11:45
Pharmacotherapy & Weight Management
University of Liverpool, Liverpool, UK
University of Birmingham, Birmingham, UK
Mon 02 15:00
OC4.3
Development of 3D thyroid follicles from primary human and murine thyrocytes.
University of Birmingham, Birmingham, UK
Workshop
1
Oral
12
Expert
13
Plenary
8
Catering and Social
9
Nurse
2
Other
10
Symposium
14
No Session Type
13
Wed 04 09:05
Conn-undrums - a deep dive into diagnostic pitfalls
St James Hospital, Dublin, Ireland
Wed 04 10:05
Low glucose, high stakes - investigation of spontaneous hypoglycaemia
University of Edinburgh, Edinburgh, UK
Mon 02 12:10
OP1.1
Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Clinical Presentation, Diagnosis, and Management
London Northwest University Hospital NHS Trust, London, UK
Mon 02 12:18
OP1.2
MECP2 as a regulator of transcription and chromatin conformation in GnRH neurons: implications for puberty.
Queen Mary University of London, London, UK
Mon 02 12:26
OP1.3
HypoMap3D: A reference spatio-cellular atlas of the mouse hypothalamus for studying neuroendocrine biology and disorders
University of Cambridge, Cambridge, UK
Mon 02 12:34
OP1.4
Autistic spectrum disorders and heterogenous pituitary phenotype in patients with AIP variants
Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mon 02 12:45
OP2.1
miR-10b-5p promotes brown adipocyte differentiation and the thermogenic program in white adipose tissue.
Nottingham Trent University, Nottingham, UK
Mon 02 12:53
OP2.2
Loss of 11β-HSD1 Attenuates Skeletal Muscle Atrophy During Glucocorticoid Therapy in Experimental Kidney Injury
University of Birmingham, Birmingham, UK
Mon 02 13:01
OP2.3
Efficacy of GLP-1 Receptor Agonists in Patients with Prader–Willi Syndrome: A Retrospective Cohort Study
Heartlands Hospital, Birmingham, UK
Mon 02 13:09
OP2.4
Biased Agonism Can Modulate Response to GLP-1R Therapy Through Altered Surface Availability in the CNS.
Imperial College London, London, UK
Mon 02 14:30
OC1.1
Replacing the early morning cortisol rise reduces fatigue and improves QoL in adrenal insufficiency: a double-blind study
Cardiff University, Cardiff, UK
Mon 02 14:45
OC1.2
Validation of prognostic biomarkers in adrenocortical carcinoma through Next-Generation Sequencing and pyrosequencing in a real-life setting.
University of Birmingham, Birmingham, UK
Mon 02 15:00
OC1.3
Serum steroid metabolomics is inferior to urine steroid metabolomics in the detection of adrenocortical carcinoma
MRC Laboratory of Medical Sciences, London, UK
Mon 02 15:15
OC1.4
Improved Wellbeing and Reduced Cardiometabolic Risks with Once-daily Low-dose Prednisolone in Adrenal Insufficiency: Interim Results from the Hyper-Aid Study
Imperial College London, London, UK
Mon 02 15:30
OC1.5
Validating the Utility of Morning Salivary Cortisone in the Assessment for Adrenal Insufficiency
The Christie NHS Foundation Trust, Manchester, UK
Mon 02 15:45
OC1.6
Childhood Androgen Excess and Metabolic Risk: A Case-Control Study in Premature Adrenarche and Adolescent Polycystic Ovary Syndrome
Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK
Mon 02 14:30
OC2.1
Peri-Prostatic Adipose Tissue Drives Obesity-Associated Prostate Cancer Aggressivity via Extracellular Vesicles and Rho GTPase Signalling
Imperial College London, London, UK
Mon 02 14:45
OC2.2
Imaging Adrenal Aldosterone Synthase Expression with [18F]AldoView PET-CT in Primary Aldosteronism
University College London, London, UK
Mon 02 15:00
OC2.3
Retrospective Review of the Management of Head and Neck Paragangliomas in a UK PPGL Centre of Excellence
University of Cambridge, Cambridge, UK
Mon 02 15:15
OC2.4
Sphingosine Kinase 2 (SPHK2) inhibition as a therapeutic strategy for Adrenocortical Carcinoma (ACC)
Queen Mary University of London, London, UK
Mon 02 15:30
OC2.5
Rationalising the use of hypertonic saline-stimulated copeptin measurements in differentiating between AVP deficiency and primary polydipsia
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Mon 02 14:30
OC3.1
Investigating fertility and reproductive ageing in a Down syndrome mouse model
Queen Mary University of London, London, UK
Mon 02 14:45
OC3.2
Kisspeptin challenge test reveals hypothalamic dysfunction in obesity-related hypogonadism
Imperial College London, London, UK
Mon 02 15:00
OC3.3
Short-Term Oestradiol Variability Across HRT Preparations in Postmenopausal Women
Imperial College London, London, UK
Mon 02 15:15
OC3.4
DNA methylation of Gonadotropin-Releasing Hormone Regulatory Genes is altered in Human Delayed Puberty
Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Mon 02 15:30
OC3.5
Improvements in Lower Extremity Alignment are Associated with Physical Functioning in Children with Achondroplasia Treated with Navepegritide: 52-Week Results from the ApproaCH Trial
Children’s Health Ireland at Temple Street, Dublin, Ireland
Mon 02 15:45
OC3.6
Comparative Effectiveness of Bariatric Surgery vs. Pharmacologic Weight Loss on Bone Health and Fracture Risk in Asian Population
County Hospital, Stafford, UK
Mon 02 14:30
OC4.1
Functional Characterization of Two Different NAH-Associated Activating TSHR Mutations
University of Birmingham, Birmingham, UK
Mon 02 14:45
OC4.2
Neutrophil count and neutropenia in newly diagnosed hyperthyroidism: Ethnic variation and TRAb–Free-T4 interaction
The Royal Wolverhampton Trust, Wolverhampton, UK
Mon 02 15:00
OC4.3
Development of 3D thyroid follicles from primary human and murine thyrocytes.
University of Birmingham, Birmingham, UK
Mon 02 15:15
OC4.4
Evaluating Levothyroxine Cessation and Thyroid Status: A City-Wide Population Record Analysis
Res Consortium, Andover, UK
Mon 02 15:30
OC4.5
Batoclimab Induces Very Rapid and Sustained Post-treatment Euthyroidism in Graves’ Disease
Johannes Gutenberg University Medical Center, Mainz, Germany
Mon 02 15:45
OC4.6
Mapping the Mutational Landscape of Thyroid Carcinoma Using Whole-Exome Sequencing
University of Leicester, Leicester, UK
Tue 03 13:20
OP3.1
A Role for Non-Muscle Myosin IIA in Adrenocortical Carcinoma
QMUL, London, UK
Tue 03 13:28
OP3.2
Redox Modulation Enhances the Metabolic Efficacy of SGLT2 Inhibition
University of Leicester, Leicester, UK
Tue 03 13:36
OP3.3
Salivary hybrid steroids and the sub-classification of primary aldosteronism: a pilot study
Manchester University NHS Foundation Trust, Manchester, UK
Tue 03 13:44
OP3.4
Weight loss induced by bariatric surgery impacts significantly on serum and urinary mineralocorticoid metabolism in men and women
Royal College of Surgeons in Ireland, Dublin, Ireland
Tue 03 13:55
OP4.1
Computer-Assisted Cytopathological Diagnosis in Pancreatic Tumours: A Systematic Review and Meta-Analysis
Imperial College London, London, UK
Tue 03 14:03
OP4.2
SGK3 and Lipid Remodelling: A Key Player in Androgen-Mediated Metabolic Dysregulation in Endocrine-Resistant Breast Cancer
Royal College of Surgeons in Ireland (RCSI), Dublin, UK
Tue 03 14:11
OP4.3
Optimising Glucocorticoid Replacement in Adrenocortical Cancer: The Role of ACTH Monitoring
Imperial College London, London, UK
Tue 03 14:19
OP4.4
GloBE-Reg: A Global Registry for Evaluating the Safety and Effectiveness of Growth Hormone Therapy Across The Age Span
University of Glasgow, Glasgow, UK
Tue 03 15:15
OC6.1
Integrative Multi-Omics Analysis Reveals Epigenetic Regulation of Placental Genes Associated with Maternal B12 Deficiency
Nottingham Trent University, Nottingham, UK
Tue 03 15:30
OC6.2
Identifying High-Risk Women After GDM: Multivariate Analysis of Routine Clinical Metrics for Postpartum Dysglycaemia
Imperial College London, London, UK
Tue 03 15:45
OC6.3
Beneficial Effect of Protein-Induced Glucose Tolerance is Independent of Protein-Induced Insulin Release
Imperial College London, London, UK
Tue 03 16:00
OC6.4
High Fracture Rates in Obesity Despite Normal Bone Mineral Density
Imperial College London, London, UK
Tue 03 16:15
OC6.5
A targeted epi-drug screen identifies HDAC6 inhibition as an enhancer of beta cell function and immune evasion
Imperial College London, London, UK
Tue 03 16:30
OC6.6
Decoding the obese duodenal cell atlas
King's College London, London, UK
Tue 03 15:15
OC7.1
Predictive value of day-7 serum cortisol for hypothalamic–pituitary–adrenal axis recovery following transsphenoidal surgery
Queen Elizabeth University Hospital, Glasgow, UK
Tue 03 15:30
OC7.2
Defective Nitric Oxide Pathway Signalling - a Link Between Premature Birth and Altered Mini-Puberty?
Queen Mary University of London, London, UK
Tue 03 15:45
OC7.3
Charting the clinical course of immune checkpoint inhibitor-related endocrinopathies amongst 833 ICI-treated patients in North Wales
Glan Clwyd Hospital, Rhyl, UK
Queen Elizabeth Hospital Birmingham and Aston University, Birmingham, UK
Tue 03 16:00
OC7.4
Peripartum increases in serum prolactin and differential mammary prolactin receptor isoform expression are associated with human secretory activation
University of Oxford, Oxford, UK
Tue 03 16:15
OC7.5
Insights into Somatostatin Analogue Response: Alterations in SSTR and Ki-67 Expression in LCC-18 Neuroendocrine Tumour Cells
Centre for Health and Life Sciences, Coventry, UK
Tue 03 16:30
OC7.6
Long-term and sustained biochemical control of acromegaly and improved quality of life with CAM2029 octreotide subcutaneous depot: final analysis of the core phase of ACROINNOVA 2
Camurus AB, Lund, Sweden
Wed 04 12:20
OP6.1
CCN family member 3 (CCN3) is a potential human osteoanabolic lactation hormone
University of Oxford, Oxford, UK
Wed 04 12:28
OP6.2
Characterisation of human sulfotransferases involved in vitamin D metabolite sulfation and population-level variation in sulfation
MRC LMS, London, UK
Wed 04 12:36
OP6.3
An Endocrine Nurse led Cinacalcet Clinic? Saving money, avoiding admissions and keeping patient safe!
Mersey and West Lancashire Teaching Hospitals NHS Trust, St Helens, UK
Wed 04 12:44
OP6.4
Efficacy and Safety of Palopegteriparatide Treatment in Adults With Hypoparathyroidism: 3-Year Results From the Phase 3 PaTHway Trial
University of Birmingham and Queen Elizabeth Hospital, Birmingham, UK
Wed 04 12:55
OP7.1
Adaptive Metabolic Plasticity Defends Body Reserves During Reproduction
Imperial College London, London, UK
Imperial College London, London, UK
Wed 04 13:03
OP7.2
Low Protein Diet Alters Embryo Morphology and 1-Carbon Metabolism in Mice
University of Nottingham, Nottingham, UK
Wed 04 13:11
OP7.3
A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women with Hypoactive Sexual Desire Disorder (HSSD) Already Receiving this as Part of Usual Care in Conjunction with Oestrogen Containing Hormone Replacement Treatment (HRT)
Salford Royal Hospital, Salford, UK
Wed 04 13:19
OP7.4
Disentangling the impact of Obesity on Reproductive, Metabolic and Adipokine Profiles in Women with or without PCOS
Imperial College London, London, UK
Mon 02 09:10
WIN1
Mon 02 09:25
WIN2
Tue 03 14:35
MTE1
Managing Congenital Adrenal Hyperplasia - Optimising Treatment Strategies
Sheffield Teaching Hospital , Sheffield, UK
Tue 03 14:20
MTE2
Belzutifan - VHL and beyond
The Francis Crick insitute , London , UK
Tue 03 14:35
MTE3
Fertility preservation in male childhood cancer
The University of Edinburgh , Edinburgh, UK
Tue 03 14:35
MTE4
Navigating the complexities of GHD: Transition to Adulthood
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK
Wed 04 08:30
Functional imaging in tricky pituitary cases
University of Cambridge, Cambridge, UK
Wed 04 08:30
Wed 04
Hormone and risk management across the lifespan in transgender patients
Queen Elizabeth University Hospital, Glasgow, UK
Wed 04 11:45
Pharmacotherapy & Weight Management
University of Liverpool, Liverpool, UK
Wed 04 11:50
Metabolic Surgery and Beyond
Imperial College Healthcare NHS Trust, London, UK
Wed 04 11:40
Updates in diagnosis and management of POI
University College London, London, UK
Wed 04 11:40
Tips for publishing impactful research
University of Edinburgh, Edinburgh, UK
Wed 04 11:50
The peer-review process
University of Birmingham, Birmingham, United Kingdom
Wed 04 12:00
Publishing case reports in EDMCR
Metropolitan Hospital, Athens, Greece
Mon 02 13:25
PL1
Autoimmune regulator and polyendocrine syndromes
University of Bergen, Bergen, Norway
Mon 02 13:55
PL2
Using kisspeptin to interrogate hypothalamic dysfunction in reproductive disorders
Imperial College, London, United Kingdom
Mon 02 16:25
PL3
Brain-body control by the hippocampus
NYU Neuroscience Institute, New York, USA
Tue 03 09:40
PL4
A 60-year odyssey with bisphosphonates, bone biology and beyond
University of Sheffield , Sheffield , UK
Tue 03 10:10
PL5
From mutation to medicine: a story of MCT8 deficiency
Erasmus Medical Center, Rotterdam, The Netherlands
Tue 03 17:15
PL6
Stress, steroids and serendipity
University of Edinburgh, Edinburgh, United Kingdom
Tue 03 17:45
PL7
Pituitary Troubles and the Mitos for the Labyrinth
Birmingham, UK
Wed 04 14:05
PL9
Title TBC
Massachusetts General Hospital, Boston, Massachusetts
Tue 03 15:15
NS2.1
TITLE TBC
Barts NHS Trust Cambridge University Hospital NHS Trust , Cambridge , UK
Tue 03 15:45
NS2.2
The role of the endocrine nurse in managing complex Cushing’s disease
St Bartholomew’s Hospital, London , UK
Tue 03 16:15
NS2.3
The patient journey and the role of patient support groups
Pituitary Ambassador for the Pituitary Foundation
Tue 03 17:45
NS3.1
Intro/ Overview
University of Oxford Hospitals, Oxford, UK
Tue 03 18:05
NS3.2
New Guidance: Hypoparathyroidism – what’s new, NICE and how nurses are integral to this
York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK
Tue 03 18:25
Mon 02 11:20
Consensus statement about Mild Autonomous Cortisol Secretion
Queen Elizabeth Hospital, Birmingham, UK
Mon 02 11:50
Introduction to HISTAR score, a tool to predict cure in primary aldosteronism
Mon 02 11:20
Introduction to Reproductive Endocrinology Endocrine Network
Imperial College London, London, UK
Mon 02 11:25
Developing a strategy to improve energy expenditure in PCOS
King's College London, London, UK
University of Edinburgh, Edinburgh, UK
Mon 02 11:20
Skeletal consequences of GLP-1 based therapies
Queen Elizabeth University Hospital, Birmingham, UK
University of Birmingham, Birmingham, UK
University of Southern Denmark , Denmark
Wed 04 10:50
Wed 04 10:58
Iodine Status in the United Kingdom
Cardiff University, Cardiff, UK
Wed 04 11:06
Using artificial intelligence to predict antithyroid drug dosage
Bournemouth
Wed 04 11:14
Information for patients with TED
British Thyroid Foundation, Harrogate , UK
Wed 04 11:22
UK clinical trials for Grave’s disease
Newcastle University, Newcastle upon Tyne, UK
Wed 04 11:29
Update on translational studies to enhance NIS function
University of Birmingham, Birmingham, UK
Wed 04 10:50
Wed 04 10:55
Identification of a non-invasive microRNA-based diagnostic biomarker panel for prostate cancer
Imperial College London, London, UK
Wed 04 11:10
Immune Check point inhibitor induced Endocrinopathy Registry
Wed 04 11:25
Mon 02 09:45
WS1.1
GLP-1 receptor agonists and metabolic improvement in PCOS
Imperial College London, London, United Kingdom
Mon 02 10:15
WS1.2
GLP-1 receptor agonists to combat addiction
University of Gothenburg, Gothenburg, Sweden
Mon 02 10:45
WS1.3
GLP-1 receptor agonists to treat liver disease
Tue 03 11:40
NS1.1
Presentation 1
Guy's & St Thomas' NHS Foundation Trust, London, UK
Tue 03 12:10
NS1.2
Presentation 2
Guy's & St Thomas' NHS Foundation Trust, London, UK
Tue 03 12:40
NS1.3
Supporting patients with Obesity
University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, Coventry, UK
Wed 04 08:30
Improving the treatment of patients with reproductive hormonal disorders
Imperial College London, London, UK
Wed 04 09:05
S4.1
Novel treatments for managing autoimmunity in Graves' disease
Newcastle University, Newcastle upon Tyne, UK
Wed 04 09:35
S4.2
Borderline thyroid dysfunction in fertility clinics
London, United Kingdom
Wed 04 10:05
S4.3
Radiofrequency ablation of benign thyroid nodules
Wed 04
OP5.1
Postgraduate Educational Methods in Diabetes, Endocrinology and Metabolism (PEMDEM): A Systematic Review of Training Approaches and Their Impact on Clinical Competence and Patient Care
University of Birmingham, Birmingham, UK
Wed 04
OP5.2
EndocrineDigiSim: A Pilot Study of Digital Endocrine Consultation Simulation for Postgraduate Medical Training
St Bartholomhew's Hospital, London, UK
Wed 04
OP5.3
Hormone Hype and Health Misinformation: Social Media Marketing of Cortisol and Testosterone.
University of Birmingham, Birmingham, UK
Wed 04
OP5.4
Enhancing Endocrine Training Through Virtual Simulation: Addressing Social Determinants of Health, Health Inequities and Multiple Long-Term Conditions
University of Birmingham, Birmingham, UK
Wed 04
OP5.5
Inpatient Hyponatraemia diagnosis and management
London Northwest University Hospital NHS Trust, London, UK
Wed 04 09:05
S6.1
Ovarian follicle activation and exposures affecting ovarian reserve
The University of Edinburgh, Edinburgh, UK
Wed 04 09:35
S6.2
The corpus luteum
University of Nebraska Medical Center, Nebraska, USA
Wed 04 10:05
S6.3
Egg freezing- meeting social and clinical needs
Kings College London, London, UK
Wed 04 16:02
HDI2.5
Building back bone and improving fracture risk – what you can do for your patients, right now
King’s College London, London, UK
Wed 04 14:50
CET1.1
What has single cell sequencing told us about the hypothalamus?
University of Cambridge, Cambridge, UK
Wed 04 15:20
CET1.2
What can mass spectrometry do for Endocrinologists?
University of Birmingham, Birmingham, UK
Wed 04 15:50
CET1.3
How can AI advance our understanding of endocrine systems
Tue 03 08:15
The Latest ESE guidance on Hypoparathyroidism
University Hospitals Birmingham, Birmingham, UK
Tue 03 08:35
ER1.1
Emerging Researcher Lecture (Science): Role of Obesity Gene PLXNA4 in Neurodevelopment and Anxiety
University of Edinburgh, Edinburgh, UK
Tue 03 08:55
ER1.2
Emerging Researcher Lecture (Clinical): Kisspeptin-54 accurately identifies the cause of delayed puberty
Imperial College London, London, UK
Tue 03 09:15
ER1.3
Best Clinical Abstract: Improved Skeletal Dynamics in Adults Treated with Palopegteriparatide for Chronic Hypoparathyroidism: 214-Week Results from the Phase 2 PaTH Forward Trial
Norfolk and Norwich University Hospital, Norwich, UK
Tue 03 09:25
ER1.4
Best Basic Abstract: Visualising microvascular changes in digestive organs during the onset of type 2 diabetes with super-resolution ultrasound
Imperial College London, London, UK
Tue 03 11:05
NKM1
Endocrine Nursing across the years - from acorns to great oaks
Guy's and St Thomas' NHS Foundation Trust, London, UK
Tue 03 10:55
OCP1
Tue 03 11:05
TAA1
My journey in medicine and endocrinology
Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United States
Tue 03 11:40
S1.1
Secretory PPGL
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Tue 03 11:55
S1.2
Insulinoma
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 03 12:10
S1.3
Paraneoplastic Cushing’s
The Christie NHS Foundation Trust, Manchester, UK
Tue 03 12:25
S1.4
Secretory ACC
Barts NHS Trust Cambridge University Hospital NHS Trust , Cambridge , UK
Tue 03 12:40
S1.5
Tricky growing indeterminate lesions (eg myelolipoma)
Newcastle Hospital NHS Foundation Trust, Newcastle , UK
Tue 03 12:55
S1.6
Adrenal mass in pregnancy
Royal Surrey Hospital, Surrey, UK
Tue 03 11:40
S2.1
The fat remembers: epigenetic changes in adipose tissue in obesity
Departement Gesundheitswissenschaften und Technologie, ETH Zurich
Tue 03 12:10
S2.2
The Role of Insulin Resistance and Adrenomedullin in Endothelial Cells
Bad Nauheim, Germany
Tue 03 12:40
S2.3
Causes and consequences of diabetes kidney disease
Tue 03 11:40
S3.1
Oral somatostatin analogue therapy for pituitary disease
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 03 12:10
S3.2
Transcription factor analysis of null cell adenomas
Beaumont Hospital, Dublin, Ireland
Tue 03 12:40
S3.3
Recognition and management of aggressive pituitary tumours
London
0 result(s) found.